Results 261 to 264 of about 54,679 (264)

Ipilimumab for Patients With Advanced Mucosal Melanoma

Oncologist, 2013
Michael A Postow, Jason J Luke, Mark J Bluth   +2 more
exaly  

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

Annals of Oncology, 2015
A M Di Giacomo, Paolo A Ascierto, Paola Queirolo   +2 more
exaly  

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders

Cancer Immunology, Immunotherapy, 2018
Thomas Eigentler, Anja Gesierich, Lucie Heinzerling   +2 more
exaly  

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

Cancer Immunology, Immunotherapy, 2013
Laurene Cagnon, Petra Baumgaertner, Olivier Michielin   +2 more
exaly